Citi Downgrades Genzyme (GENZ) to Hold, Citing Lack of Visibility
Tweet Send to a Friend
Citi downgrades Genzyme Corp (Nasdaq: GENZ) from Buy to Hold. Price target lowered from $81 to $61.
Citi ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Citi ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


